Example: air traffic controller
PRESS RELEASE - camel-ids.com

PRESS RELEASE - camel-ids.com

Back to document page

PRESS RELEASE 1 Camel-IDS completes EUR 37m Series A financing to develop cancer-targeted radiopharmaceuticals • Camel-IDS is developing new radiopharmaceuticals based on linking single domain antibody fragments with radioisotopes to treat cancer

  Camels

Download PRESS RELEASE - camel-ids.com


Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries